名稱 | CCDC6-RET WT/BaF3 |
型號(hào) | CBP73214 |
報(bào)價(jià) | ![]() |
特點(diǎn) | CCDC6-RET WT/BaF3,母細(xì)胞:BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 【連載-企業(yè)參考品】 急性淋巴細(xì)胞白血病的診斷參考品的選擇
- PDGFRA靶點(diǎn)藥物細(xì)胞篩選模型
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- STING激動(dòng)劑和拮抗劑的篩選
- TIGIT&PVRIG雙靶點(diǎn)細(xì)胞篩選模型
- 人結(jié)腸癌細(xì)胞株培養(yǎng)操作步驟
- atcc細(xì)胞購(gòu)買途徑如何分辨清楚?
- 降糖&減肥明星靶點(diǎn):GLP1R/GIPR/GCGR
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌(NSCLC)
- 圣誕節(jié)日,這株腫瘤細(xì)胞你的圣誕襪里,有嗎
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73214CCDC6-RET WT/BaF3

- 詳細(xì)內(nèi)容
CBP73214 | |
I. Introduction | |
Cell Line Name: | CCDC6-RET WT/BaF3 |
Host Cell: | BA/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
III. Representative Data | |
1. WB of CCDC6-RET WT/BaF3WT | |
2. Sanger of CCDC6-RET WT/BaF3 Figure 2. Breakpoint of CCDC6-RET WT/BaF3 | |
2. Anti-proliferation assay | |
Figure 3. CTG assay of for CCDC6-RET WT/BaF3 Stable Cell Line,the Gi50 was 137.3nM. |